Nuvation Bio Inc. (NUVB) closed the last trading session at $8.58, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $11.33 indicates a 32.1% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $2.78. While the lowest estimate of $8.00 indicates a 6.8% decline from the current price level, the most optimistic analyst ex ...

Core Viewpoint - Amazon (AMZN) shares have increased by 3% over the past four weeks, closing at $227.35, with a mean price target of $295.8 indicating a potential upside of 30.1% according to Wall Street analysts [1]. Price Targets - The average of 54 short-term price targets ranges from a low of $230.00 to a high of $360.00, with a standard deviation of $24.81, suggesting variability in analyst estimates [2]. - The lowest estimate indicates a 1.2% increase from the current price, while the highest estimate suggests a 58.4% upside [2]. Analyst Consensus and Earnings Estimates - Analysts show strong agreement in revising earnings estimates higher, which is a positive indicator for potential stock upside [4][11]. - The Zacks Consensus Estimate for the current year has remained stable, with no negative revisions and one estimate moving higher [12]. - AMZN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' ability to set unbiased targets has been questioned [3][10]. - Price targets can often be inflated due to business incentives of firms associated with the stocks [8]. - A low standard deviation in price targets indicates a high degree of agreement among analysts, which can be a starting point for further research [9].

Shares of Theravance Biopharma (TBPH) have gained 1.7% over the past four weeks to close the last trading session at $18.79, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $26.71 indicates a potential upside of 42.2%.The average comprises seven short-term price targets ranging from a low of $13.00 to a high of $42.00, with a standard deviation of $11.1. While the lowest estimat ...

Core Viewpoint - AvePoint, Inc. (AVPT) shows significant upside potential with a mean price target of $20, indicating a 49.3% increase from the current price of $13.4 [1] Price Targets and Estimates - The mean estimate consists of 12 short-term price targets with a standard deviation of $4.07, suggesting variability in analyst predictions [2] - The lowest estimate is $16.00, indicating a 19.4% increase, while the highest estimate is $28.00, suggesting a 109% increase [2] - Analysts' price targets can often mislead investors, as empirical research shows they rarely indicate actual stock price movements [7][10] Earnings Estimates and Analyst Agreement - Analysts are optimistic about AVPT's earnings, with a strong consensus on higher EPS estimates, which correlates with potential stock price increases [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 115.4%, with no negative revisions [12] - AVPT holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14]

Shares of Slide Insurance Holdings, Inc. (SLDE) have gained 5.6% over the past four weeks to close the last trading session at $16.89, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $22.8 indicates a potential upside of 35%.The average comprises five short-term price targets ranging from a low of $21.00 to a high of $25.00, with a standard deviation of $2.05. While the lowest e ...

Core Viewpoint - Crexendo (CXDO) shares have increased by 8.6% in the past four weeks, closing at $6.96, with a potential upside of 27.9% based on Wall Street analysts' mean price target of $8.9 [1][11]. Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $0.74, indicating variability among analysts [2]. - The lowest price target of $8.00 suggests a 14.9% increase, while the highest target of $10.00 indicates a potential surge of 43.7% [2]. - A low standard deviation signifies strong agreement among analysts regarding the stock's price movement [9]. Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism about CXDO's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11]. - The Zacks Consensus Estimate for the current year has risen by 8.7% over the past month, with two estimates increasing and no negative revisions [12]. - CXDO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Caution on Price Targets - While consensus price targets are popular among investors, they may not reliably indicate actual stock price movements [3][7]. - Analysts often set optimistic price targets due to business incentives, which can lead to inflated estimates [8]. - Investors should approach price targets with skepticism and not rely solely on them for investment decisions [10].

Core Viewpoint - Cummins Inc. is positioned as a leading player in the engine and power generation market, demonstrating resilience and growth potential despite market volatility [1][4]. Company Overview - Cummins Inc. designs, manufactures, and distributes engines, filtration, and power generation products, serving customers in over 190 countries through approximately 600 company-owned and independent distributor locations and over 7,600 dealer locations [1]. - The company competes with major industrial players such as Caterpillar and General Electric [1]. Stock Performance - As of November 25, 2025, Cummins' stock was trading at $485.62, with a price target set at $500 by UBS, indicating a potential upside of approximately 2.96% [2]. - The stock has shown positive momentum, reflecting an increase of 2.77%, or $13.11, amidst significant market volatility [3]. - CMI's stock has fluctuated between a low of $476.98 and a high of $490.30 on the day, with the latter being its highest price over the past year [4]. - The lowest price for CMI in the past year was $260.02, indicating resilience and growth potential [4]. Market Context - The stock market has experienced significant volatility, particularly following NVIDIA Corp's earnings report, but optimism returned after comments from New York Fed President John Williams regarding potential rate cuts [3]. - Major indices, including the Dow Jones Industrial Average, S&P 500, and NASDAQ, closed higher, reflecting a positive market sentiment [3]. - Cummins has a market capitalization of approximately $66.86 billion, maintaining its status as a significant player in the industrial sector [4]. - Today's trading volume for CMI was 1,288,788 shares, indicating active investor interest [4].

Core Viewpoint - LATAM (LTM) stock shows potential for upside, with a mean price target of $56.73 indicating a 25.2% increase from the current price of $45.33 [1] Price Targets - The average price target consists of four estimates ranging from $50.90 to $60.00, with a standard deviation of $4.32, suggesting a consensus among analysts [2] - The lowest estimate indicates a 12.3% increase, while the highest suggests a 32.4% upside [2] - A low standard deviation indicates greater agreement among analysts regarding price movement [9] Analyst Sentiment - Analysts are optimistic about LTM's earnings prospects, as indicated by a positive trend in earnings estimate revisions [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 5.4%, with two estimates moving higher and no negative revisions [12] Zacks Rank - LTM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Targets - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14]

Core Viewpoint - Shares of Profound Medical (PROF) have increased by 6.3% recently, with a mean price target of $12.31 suggesting a potential upside of 97.6% from the current price of $6.23 [1][2] Price Targets - The average price target for PROF ranges from a low of $11.00 to a high of $15.25, with a standard deviation of $2.01, indicating variability among analysts [2] - The lowest estimate suggests a 76.6% increase, while the highest indicates a 144.8% upside [2] Analyst Consensus and Earnings Estimates - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 7.6%, with two estimates moving higher and no negative revisions [12] Zacks Rank - PROF holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Targets - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14]

Core Viewpoint - Foghorn Therapeutics Inc. (FHTX) has seen a 23.3% increase in share price over the past four weeks, closing at $5.02, with analysts suggesting a potential upside of 133.3% based on a mean price target of $11.71 [1][11]. Price Targets and Analyst Estimates - The mean price target is derived from seven short-term estimates, with a standard deviation of $2.06, indicating variability among analysts [2]. - The lowest price target of $9.00 suggests a 79.3% increase, while the highest target of $14.00 indicates a potential surge of 178.9% [2]. - A low standard deviation signifies strong agreement among analysts regarding the stock's price movement [9]. Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism about FHTX's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11]. - The Zacks Consensus Estimate for the current year has risen by 2.6% over the past month, with three estimates increasing and no negative revisions [12]. - FHTX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Caution on Price Targets - While price targets are commonly referenced by investors, their reliability is often questioned, as they can mislead rather than guide [7][10]. - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]. - Despite the skepticism surrounding price targets, a consensus direction can provide a useful starting point for further research [9][14].